Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2010

01-01-2010 | Clinical Research

Mitochondrial DNA Content in Human Omental Adipose Tissue

Authors: Andrea Lindinger, Ralph Peterli, Thomas Peters, Beatrice Kern, Markus von Flüe, Martine Calame, Matthias Hoch, Alex N. Eberle, Peter W. Lindinger

Published in: Obesity Surgery | Issue 1/2010

Login to get access

Abstract

Background

Impairment of mitochondrial function plays an important role in obesity and the development of insulin resistance. The aim of this project was to investigate the mitochondrial DNA copy number in human omental adipose tissue with respect to obesity.

Methods

The mitochondrial DNA (mtDNA) content per single adipocyte derived from abdominal omental adipose tissue was determined by quantitative RT-PCR in a group of 75 patients, consisting of obese and morbidly obese subjects, as well as non-obese controls. Additionally, basal metabolic rate and fat oxidation rate were recorded and expressed as total values or per kilogram fat mass.

Results

MtDNA content is associated with obesity. Higher body mass index (BMI) resulted in a significantly elevated mtDNA count (ratio = 1.56; p = 0.0331) comparing non-obese (BMI < 30) to obese volunteers (BMI ≥ 30). The mtDNA count per cell was not correlated with age or gender. Diabetic patients showed a trend toward reduced mtDNA content. A seasonal change in mtDNA copy number could not be identified. In addition, a substudy investigating the basal metabolic rate and the fasting fat oxidation did not reveal any associations to the mtDNA count.

Conclusions

The mtDNA content per cell of omental adipose tissue did not correlate with various clinical parameters but tended to be reduced in patients with diabetes, which may partly explain the impairment of mitochondrial function observed in insulin resistance. Furthermore, the mtDNA content was significantly increased in patients suffering from obesity (BMI above 30). This might reflect a compensatory response to the development of obesity, which is associated with impairment of mitochondrial function.
Literature
1.
Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277–359.CrossRefPubMed
2.
Diamond F. The endocrine function of adipose tissue. Growth Genet Horm. 2002;18(2):17–22.
3.
4.
Maassen JA. Mitochondrial dysfunction in adipocytes: the culprit in type 2 diabetes? Diabetologia. 2006;49(4):619–20.CrossRefPubMed
5.
Choo HJ, Kim JH, Kwon OB, et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia. 2006;49:784–91.CrossRefPubMed
6.
Guilherme A, Virbasius JV, Czech MP, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–77.CrossRefPubMed
7.
Petersen KF, Befroy D, Shulman GI, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;500(5622):1140–2.CrossRef
8.
Civitarese AE, Ravussin E. Minireview: mitochondrial energetics and insulin resistance. Endocrinology. 2007;149(3):950–4.CrossRef
9.
10.
Kuroshima A. Brown adipose tissue thermogenesis as a physiological strategy for adaptation. Jpn J Physiol. 1993;43(43):117.CrossRefPubMed
11.
Justo R, Oliver J, Gianotti M. Brown adipose tissue mitochondrial subpopulations show different morphological and thermogenic characteristics. Mitochondrion. 2005;5(1):45–53.CrossRefPubMed
12.
Collins TJ, Bootman MD. Mitochondria are morphologically heterogenous within cells. J Exp Biol. 2003;206:1993–2000.CrossRefPubMed
13.
Menziens RA, Gold PH. The turnover of mitochondria in a variety of tissues of young adult and aged rats. J Biol Chem. 1970;246(8):2425–9.
14.
Masuyama M, Iida R, Matsuki T, et al. Quantitative change in mitochondrial DNA content in various mouse tissues during aging. Biochim Biophys Acta. 2005;1723:302–8.PubMed
15.
Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004;18:357–68.CrossRefPubMed
16.
Wu Z, Puigserver P, Spiegelman BM, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 1999;98:115–24.CrossRefPubMed
17.
van Marken Lichtenbelt WD, Vanhommering JW, Jaap Teule GJ, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500–8.CrossRefPubMed
18.
Chan DC. Mitochondrial fusion and fission in mammals. Ann Rev Cell Dev Biol. 2006;22:79–99.CrossRef
19.
Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2007;8:870–9.CrossRefPubMed
20.
Mingrone G, Manco M, Zorzano A, et al. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia. 2005;48:2108–14.CrossRefPubMed
21.
Bach D, Pich S, Zorzano A, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. J Biol Chem. 2003;278(19):17190–7.CrossRefPubMed
22.
Wilson-Fritch L, Nicoloro S, Corvera S, et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004;114(9):1281–9.PubMed
23.
Peterli R, Wöllnerhanssen B, von Flüe M, et al. Prospective study of a two-stage operative concept in the treatment of morbid obesity: primary Lap-Band followed if needed by sleeve gastroectomy with duodenal switch. Obes Surg. 2007;17:334–40.CrossRefPubMed
24.
Woelnerhanssen B, Kern B, Peterli R, et al. Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients. Surgery of Obesity and Related Disease. 2008;4:500–6.CrossRef
25.
Bogacka I, Xie H, Smith SR, et al. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes. 2005;54:1392–9.CrossRefPubMed
26.
Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. Springer: New York; 2000.
27.
Barazzoni R, Short KR, Sreekumaran Nair K. Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart. JBC. 2000;275(5):3343–7.CrossRef
28.
Colom B, Alcolea MP, Garcia-Palmer FJ, et al. Skeletal muscle of female rats exhibit higher mitochondrial mass and oxidative-phosphorylative capacities compared to males. Cell Physiol Biochem. 2007;19:205–12.CrossRefPubMed
29.
Mollica MP, Lionetti L, Iossa S, et al. Cold exposure differently influences mitochondrial energy efficiacy in rat liver and skeletal muscle. FEBS Lett. 2005;579:1978–82.CrossRefPubMed
30.
Needergard J, Bengtssen T. Unexpected evidence of brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293:E444–52.CrossRef
31.
Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697–738.CrossRefPubMed
32.
Maassen JA. Mitochondrial diabetes: pathophysiology, clinical presentation, and genetic analysis. Am J Med Gen (Semin. Med. Genet.). 2002;115:66–70.CrossRef
33.
Marcuello A, González-Alonso J, Díez-Sánchez C, et al. Skeletal muscle mitochondrial DNA content in exercising humans. J Appl Physiol. 2005;99:1372–7.CrossRefPubMed
34.
35.
Kaaman M, Sparks LM, Arner P, et al. Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia. 2007;50:2526–33.CrossRefPubMed
36.
Miller FJ, Rosenfeldt FL, Nagley P, et al. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of changes of copy number with age. Nucleic Acids Res. 2003;31(11):e61.CrossRefPubMed
37.
Rajala MW, Scherer PE. Minireview: the adipocyte—at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003;144(9):3765–73.CrossRefPubMed
38.
Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nat Med. 2006;444:847–53.CrossRef
39.
Ferranti SD, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54:945–55.CrossRefPubMed
40.
Robin ED, Wong R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol. 1988;136:507–13.CrossRefPubMed
41.
Cypess AM, Lehmann S, Kahn CR, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360:1509–17.CrossRefPubMed
42.
Virtanen KA, Lidell ME, Nuutila P, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360:1518–25.CrossRefPubMed
43.
Befroy DE, Petersen KF, Shulman GI, et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes. 2007;56:1376–81.CrossRefPubMed
44.
Hellmér J, Marcus C, Arner P, et al. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab. 1992;75(1):15–20.CrossRefPubMed
45.
van Harmelen V, Dicker A, Arner P, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes. 2002;51:2029–36.CrossRefPubMed
46.
Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83(3):847–50.CrossRefPubMed
47.
Arvidsson E, Blomqvist L, Ryden M. Depot-specific differences in perilipin mRNA but not protein expression in obesity. J Intern Med. 2004;255:595–601.CrossRefPubMed
48.
Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance. Diabetes. 2000;49:677–83.CrossRefPubMed
49.
Capkova M, Houstek J, Zeman J, et al. Activities of cytochrome c oxidase and citrate synthase in lymphocates of obese and normal-weight subjects. IJO. 2002;26:1110–7.CrossRef
50.
Kim JY, Hickner RC, Houmard JA, et al. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocriol Metab. 2000;279:1039–44.
51.
Crescenzo R, Bianco F, Iossa S, et al. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity. 2008;16:958–64.CrossRef
Metadata
Title
Mitochondrial DNA Content in Human Omental Adipose Tissue
Authors
Andrea Lindinger
Ralph Peterli
Thomas Peters
Beatrice Kern
Markus von Flüe
Martine Calame
Matthias Hoch
Alex N. Eberle
Peter W. Lindinger
Publication date
01-01-2010
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 1/2010
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-009-9987-3

Other articles of this Issue 1/2010

Obesity Surgery 1/2010 Go to the issue

Case Report

Bariatric Surgery in the Management of Childhood Obesity: Should There be an Age Limit?

Clinical Research

Clinical Predictors of Obstructive Sleep Apnea in Asian Bariatric Patients

Clinical Research

Variation of Outcome in Weight Loss with Band Volume Adjustments under Clinical and Radiological Control Following Laparoscopic Adjustable Gastric Banding

Clinical Research

The Gut Hormone Response Following Roux-en-Y Gastric Bypass: Cross-sectional and Prospective Study

Clinical Report

Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy

Case Report

Roux-en-Y Gastric Bypass in an Adolescent Patient with Bardet–Biedl Syndrome, a Monogenic Obesity Disorder